• 1
    Moosgaard B, Vestergaard P, Heickendorff L, Melsen F, Christiansen P, Mosekilde L. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol (Oxf) 2005; 63: 50613.
  • 2
    Ogard CG, Engelmann MD, Kistorp C, Nielsen SL, Vestergaard H. Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism. Clin Endocrinol (Oxf) 2005; 63: 4938.
  • 3
    Farahnak P, Larfars G, Sten-Linder M, Nilsson IL. Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers. J Clin Endocrinol Metab 2011; 96: 21128.
  • 4
    Rodgers SE, Lew JI, Solorzano CC. Primary hyperparathyroidism. Curr Opin Oncol 2008; 20: 528.
  • 5
    Bollerslev J, Jansson S, Mollerup CL et al. Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 2007; 92: 168792.
  • 6
    Bollerslev J, Rosen T, Mollerup CL et al. Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2009; 94: 225561.
  • 7
    Hagstrom E, Hellman P, Larsson TE et al. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 2009; 119: 276571.
  • 8
    Bu DX, Erl W, de Martin R, Hansson GK, Yan ZQ. IKKbeta-dependent NF-kappaB pathway controls vascular inflammation and intimal hyperplasia. FASEB J 2005; 19: 12935.
  • 9
    Delneste Y, Charbonnier P, Herbault N et al. Interferon-gamma switches monocyte differentiation from dendritic cells to macrophages. Blood 2003; 101: 14350.
  • 10
    Pedersen ER, Midttun O, Ueland PM et al. Systemic markers of interferon-gamma-mediated immune activation and long-term prognosis in patients with stable coronary artery disease. Arterioscler Thromb Vasc Biol 2011; 31: 698704.
  • 11
    Schrocksnadel K, Wirleitner B, Winkler C, Fuchs D. Monitoring tryptophan metabolism in chronic immune activation. Clin Chim Acta 2006; 364: 8290.
  • 12
    Huber C, Batchelor JR, Fuchs D et al. Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med 1984; 160: 3106.
  • 13
    Lui A, Lumeng L, Aronoff GR, Li TK. Relationship between body store of vitamin B6 and plasma pyridoxal-P clearance: metabolic balance studies in humans. J Lab Clin Med 1985; 106: 4917.
  • 14
    Cheng CH, Lin PT, Liaw YP et al. Plasma pyridoxal 5′-phosphate and high-sensitivity C-reactive protein are independently associated with an increased risk of coronary artery disease. Nutrition 2008; 24: 23944.
  • 15
    Chiang EP, Selhub J, Bagley PJ, Dallal G, Roubenoff R. Pyridoxine supplementation corrects vitamin B6 deficiency but does not improve inflammation in patients with rheumatoid arthritis. Arthritis Res Ther 2005; 7: R140411.
  • 16
    Shen J, Lai CQ, Mattei J, Ordovas JM, Tucker KL. Association of vitamin B-6 status with inflammation, oxidative stress, and chronic inflammatory conditions: the Boston Puerto Rican Health Study. Am J Clin Nutr 2010; 91: 33742.
  • 17
    Christensen MH, Dankel SN, Nordbo Y et al. Primary hyperparathyroidism influences the expression of inflammatory and metabolic genes in adipose tissue. PLoS One 2011; 6: e20481.
  • 18
    Midttun O, Hustad S, Ueland PM. Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 2009; 23: 13719.
  • 19
    Werner ER, Fuchs D, Hausen A, Reibnegger G, Wachter H. Simultaneous determination of neopterin and creatinine in serum with solid-phase extraction and on-line elution liquid chromatography. Clin Chem 1987; 33: 202833.
  • 20
    Fuchs D, Milstien S, Kramer A et al. Urinary neopterin concentrations vs total neopterins for clinical utility. Clin Chem 1989; 35: 23057.
  • 21
    Kelleher BP, Broin SD. Microbiological assay for vitamin B12 performed in 96-well microtitre plates. J Clin Pathol 1991; 44: 5925.
  • 22
    Molloy AM, Scott JM. Microbiological assay for serum, plasma, and red cell folate using cryopreserved, microtiter plate method. Methods Enzymol 1997; 281: 4353.
  • 23
    Holm PI, Ueland PM, Kvalheim G, Lien EA. Determination of choline, betaine, and dimethylglycine in plasma by a high-throughput method based on normal-phase chromatography-tandem mass spectrometry. Clin Chem 2003; 49: 28694.
  • 24
    Payne RB, Little AJ, Williams RB, Milner JR. Interpretation of serum calcium in patients with abnormal serum proteins. Br Med J 1973; 4: 6436.
  • 25
    Levey AS, Coresh J, Greene T et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007; 53: 76672.
  • 26
    Koenker RW. Quantile Regression. Cambridge, UK: Cambridge University Press, 2005.
  • 27
    Ball HJ, Sanchez-Perez A, Weiser S et al. Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice. Gene 2007; 396: 20313.
  • 28
    Fuchs D, Moller AA, Reibnegger G et al. Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection. Immunol Lett 1991; 28: 20711.
  • 29
    Almqvist EG, Bondeson AG, Bondeson L, Svensson J. Increased markers of inflammation and endothelial dysfunction in patients with mild primary hyperparathyroidism. Scand J Clin Lab Invest 2011; 71: 13944.
  • 30
    Greenfield EM, Gornik SA, Horowitz MC, Donahue HJ, Shaw SM. Regulation of cytokine expression in osteoblasts by parathyroid hormone: rapid stimulation of interleukin-6 and leukemia inhibitory factor mRNA. J Bone Miner Res 1993; 8: 116371.
  • 31
    Pirih FQ, Michalski MN, Cho SW et al. Parathyroid hormone mediates hematopoietic cell expansion through interleukin-6. PLoS One 2010; 5: e13657.
  • 32
    Mihara M, Hashizume M, Yoshida H, Suzuki M, Shiina M. IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clin Sci (Lond) 2012; 122: 14359.
  • 33
    Lotto V, Choi SW, Friso S. Vitamin B6: a challenging link between nutrition and inflammation in CVD. Br J Nutr 2011; 13: 113.
  • 34
    Ulvik A, Midttun O, Ringdal Pedersen E, Nygard O, Ueland PM. Association of plasma B-6 vitamers with systemic markers of inflammation before and after pyridoxine treatment in patients with stable angina pectoris. Am J Clin Nutr 2012; 95: 10728.
  • 35
    Kwak HK, Hansen CM, Leklem JE, Hardin K, Shultz TD. Improved vitamin B-6 status is positively related to lymphocyte proliferation in young women consuming a controlled diet. J Nutr 2002; 132: 330813.
  • 36
    Price JM, Brown RR, Yess N. Testing the functional capacity of the tryptophan-niacin pathway in man by analysis of urinary metabolites. Adv Metab Disord 1965; 2: 159225.
  • 37
    Midttun O, Ulvik A, Ringdal Pedersen E et al. Low plasma vitamin B-6 status affects metabolism through the kynurenine pathway in cardiovascular patients with systemic inflammation. J Nutr 2011; 141: 6117.
  • 38
    Christiansen P, Steiniche T, Brixen K et al. Primary hyperparathyroidism: biochemical markers and bone mineral density at multiple skeletal sites in Danish patients. Bone 1997; 21: 939.
  • 39
    Nakaoka D, Sugimoto T, Kobayashi T, Yamaguchi T, Kobayashi A, Chihara K. Prediction of bone mass change after parathyroidectomy in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 2000; 85: 19017.
  • 40
    Iba K, Takada J, Yamashita T. The serum level of bone-specific alkaline phosphatase activity is associated with aortic calcification in osteoporosis patients. J Bone Miner Metab 2004; 22: 5946.
  • 41
    Nayeem F, Anderson KE, Nagamani M, Grady JJ, Lu LJ. Alkaline phosphatase and percentage body fat predict circulating C-reactive protein in premenopausal women. Biomarkers 2010; 15: 66370.
  • 42
    Shantouf RS, Budoff MJ, Ahmadi N et al. Total and individual coronary artery calcium scores as independent predictors of mortality in hemodialysis patients. Am J Nephrol 2010; 31: 41925.
  • 43
    Martins MJ, Azevedo I. Let's think in alkaline phosphatase at heart function. Int J Cardiol 2010; 144: 3334.
  • 44
    Bitsch R. Vitamin B6. Int J Vitam Nutr Res 1993; 63: 27882.
  • 45
    Ink SL, Henderson LM. Vitamin B6 metabolism. Annu Rev Nutr 1984; 4: 45570.
  • 46
    Brussaard JH, Lowik MR, van den Berg H, Brants HA, Bemelmans W. Dietary and other determinants of vitamin B6 parameters. Eur J Clin Nutr 1997; 51(Suppl 3): S3945.
  • 47
    Ashley DV, Barclay DV, Chauffard FA, Moennoz D, Leathwood PD. Plasma amino acid responses in humans to evening meals of differing nutritional composition. Am J Clin Nutr 1982; 36: 14353.